Sign in

CIK 0001661998

  • Non-accelerated filer
  • Smaller reporting company

Q32 Bio Inc.

Sign in to watch
Ticker
QTTB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473468154
Phone
+1 781-999-0232
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Former names
Q32 Bio Inc., Homology Medicines, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$320,396
in 6 filings

Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-03-27 Flynn James E Director Grant or award · Stock Option (Right to Buy) +31,160 31,160
2018-03-27 Thistle Mary Director Grant or award · Employee stock option +31,160 31,160
2018-03-27 TZIANABOS ARTHUR President & CEO Grant or award · Employee stock option +92,376 92,376
2018-03-27 Wheeler Cameron Director Grant or award · Employee stock option +31,160 31,160
2018-03-27 Seymour Albert Chief Scientific Officer Grant or award · Employee stock option +66,501 66,501
2018-03-27 PARMAR KUSH Director Grant or award · Employee stock option +31,160 31,160
2018-03-27 Gregory Richard J. Director Grant or award · Employee stock option +31,160 31,160
2018-03-27 Patterson Matthew R Director Grant or award · Employee stock option +8,360 8,360
2018-03-27 Rasty Siyamak Chief Operating Officer Grant or award · Employee stock option +30,780 30,780
2018-03-27 Smith W Bradford CFO, Treasurer & Secretary Grant or award · Employee stock option +49,711 49,711
2018-03-27 GILLIS STEVEN Director Grant or award · Employee stock option +31,160 31,160
2018-03-27 SHAH MAHENDRA Director Grant or award · Employee stock options +31,160 31,160

Page 25 of 25 · 492 trades